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Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder originally described in fam-
ilies of Portuguese-Azorean ancestry. The cloning of the MJD1 gene allowed identification of the disease in many
other populations, and MJD is now known to be the most common cause of dominant spinocerebellar ataxia. The
hypothesis that its present world distribution could result from the spread of an original founder mutation has
been raised, both at historical and molecular levels. In the present study, we tested this hypothesis by linkage-
disequilibrium analysis of tightly linked polymorphisms and by haplotype comparison, in 249 families from different
countries. We typed five microsatellite markers surrounding the MJD1 locus (D14S1015, D14S995, D14S973,
D14S1016, and D14S977), and three intragenic single–base-pair polymorphisms (A669TG/G669TG,C987GG/G987GG,
and TAA1118/TAC1118). The results show two different haplotypes, specific to the island of origin, in families of
Azorean extraction. In families from mainland Portugal, both Azorean haplotypes can be found. The majority of
the non-Portuguese families also share the same intragenic haplotype seen in the families coming from the island
of Flores, but at least three other haplotypes were seen. These findings suggest two introductions of the mutation
into the Portuguese population. Worldwide, the sharing of one intragenic haplotype by the majority of the families
studied implies a founder mutation in MJD.
Machado-Joseph disease (MJD [MIM 109150]) is an
autosomal dominant spinocerebellar degeneration as-
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sociated with a variety of clinical manifestations, in-
cluding ataxia, progressive external ophthalmoplegia,
pyramidal signs, dystonia with rigidity, and distal my-
otrophies (Coutinho et al. 1977; Coutinho and Andrade
1978). The first descriptions of MJD came from families
originating from the islands of the Azores (Nakano et
al. 1972; Woods and Schaumburg 1972; Rosenberg et
al. 1976), but the disease was later identified in families
from many other ethnic origins (Sequeiros and Coutinho
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Table 1
Overall LD Analysis
Marker Allele d P
D14S1015 2 .11 .02
6 .38 .001
A/G A .66 .001
C/G C .74 .001
C/A A .77 .001
D14S973 3 .39 .001
D14S1016 7 .44 .001
10 .18 .001
D14S977 3 .16 .001
6 .15 .001
D14S995 11 .37 .001
1993) and is now known to be the most common of the
dominant spinocerebellar ataxias (Ranum et al. 1995;
Scho¨ls et al. 1995; Silveira et al. 1998).
The ancestral origin of the MJD mutation and the
presence of a founder effect that would account for the
worldwide distribution of the disease have been the
source of much speculation over the years (Sequeiros
1989; Sequeiros and Coutinho 1993; Stevanin et al.
1995; Takiyama et al. 1995; Gaspar et al. 1996; Stevanin
et al. 1997). In the Azores, the disease is mainly present
in two islands, Sa˜o Miguel and Flores. A founder effect
was thought to account for the high frequency of MJD
in the archipelago; the mutation would have arisen in
mainland Portugal and later would have been introduced
into the isolated Azorean archipelago during its colo-
nization (Sequeiros and Coutinho 1993). The Portuguese
sea travels of the late-15th and 16th centuries could
explain the presence of MJD in countries like India,
China, Japan, and others.
The MJD locus was mapped to chromosome 14q32.1
(Takiyama et al. 1993), the gene was identified (Ka-
waguchi et al. 1994), and the causative mutation was
shown to be the expansion of a polymorphic CAG repeat
within the coding region of a novel gene, MJD1. Several
researchers previously have conducted linkage disequi-
librium (LD) analyses between the MJD1 locus and
marker alleles surrounding it (Stevanin et al. 1995; Ta-
kiyama et al. 1995; Gaspar et al. 1996; Stevanin et al.
1997). We and others found preliminary evidence con-
sistent with the existence of a founder mutation in MJD;
surprisingly, our results were also suggestive of two dis-
tinct haplotypes in each of the islands of Sa˜o Miguel
and Flores (Gaspar et al. 1996); however, several factors
rendered our results inconclusive, and recombination
events giving rise to the different haplotypes could not
be ruled out completely.
In an attempt to gain insight into the ancestral origin
and spread of the MJD mutation, we performed an ex-
tensive haplotype study using five closely linked markers
and three intragenic single–base-pair polymorphisms, in
a large group of families representing the world popu-
lation affected with MJD. Here we present evidence that
supports the existence of one intragenic haplotype as-
sociated with the MJD1 allele in the majority of the
world MJD families, and we confirm the existence of
two different haplotypes in the Azores and mainland
Portugal.
Included in this study were 249 families affected by
MJD, with various ethnic backgrounds. The origins of
the families were: the Azores (specifically the islands of
Flores, Sa˜o Miguel, and Graciosa), mainland Portugal,
Brazil, Spain, China, Taiwan, Germany, Japan, France,
the United Kingdom, Belgium, Canada, the United
States, Norway, India, the British West Indies, Ghana,
Holland, Yemen, Morocco, French Guyana, Cambodia,
the Ivory Coast, and Algeria. To determine genotype
phase, we selected one affected individual from each
family and both parents, when available, for a total of
601 individuals. Control subjects consisted of 388 un-
related individuals matched for ethnic origins to our
study’s MJD population; of these, 124 individuals (with
no known links to any of the MJD families) were spe-
cifically collected in the islands of Flores and Sa˜o Miguel
in the Azores and were used as controls for the Azorean
MJD subpopulation.
Blood samples were obtained from individuals after
informed consent was obtained. Genomic DNA was ex-
tracted from lymphocytes or from MJD pathological
material, following standard procedures (Sambrook et
al. 1989).
Five microsatellite markers flanking the MJD1 lo-
cus—D14S1015, D14S995, D14S973, D14S1016, and
D14S977—and three intragenic single–base-pair poly-
morphisms were genotyped in the families and control
individuals. The three intragenic markers were A669TG/
G669TG, C987GG/G987GG, and a polymorphism involving
the STOP codon, TAA1118/TAC1118 (Goto et al. 1997;
Maciel et al. 1999). For simplification, these polymor-
phisms will be referred to as “A/G,” “C/G,” and “A/
C,” respectively.
Amplification of the A/G polymorphism was carried
out using primers MJD1VSR (TACTAGAGCTTATTT-
GCCAG) and MJD734R (CAGAGCCCTCTGCAAAT-
CCT). PCR products were visualized by SSCP analysis
using a 0.5% MDE gel (FMC BioProducts) containing
5% glycerol. Amplification conditions were as follows:
initial denaturation for 5 min at 94C, followed by 30
cycles of 1 min at 94C, 1 min at 56C, and 1 min at
72C, and a final elongation step of 5 min at 72C.
Detection of the C/G polymorphism was achieved by
allele-specific PCR using primers ASP1 (ACTCTGTCC-
TGATAGGTCCCC) or ASP2 (ACTCTGTCCTGA-
TAGGTCCCG), in combination with MJD52 (Kawa-
guchi et al. 1994). The STOP codon polymorphism A/
C was also detected by allele-specific PCR using primers
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A-C-A .02 .72 .71 !.001
A-C-C .06 0 … …
A-G-A .04 .03 .01 NS
A-G-C .13 0 … …
G-C-A .06 0 … …
G-C-C .19 0 … …
G-G-A .12 .01 .12 NS
G-G-C .38 .22 .26 .003
a NS p not significant.
Figure 1 Overall intragenic haplotype frequencies. Frequency of the eight possible haplotypes formed by the three intragenic polymor-
phisms. All eight combinations were present in the control population; in contrast, only four of the possible haplotypes were seen in the MJD
families, with haplotype A-C-A being present in 170% of the total MJD families used in this study.
ASP3 (GCAAAAATCACATGGAGCTCT) or ASP4
(GCAAAAATCACATGGAGCTCG), together with
MJD52. In both cases, PCR was performed using con-
ditions described elsewhere (Kawaguchi et al. 1994), ex-
cept for the annealing step, which was performed at
61C for 30 s.
Only phase-known genotypes were included in the
statistical analysis of LD between marker alleles and the
MJD1 allele. Differences in the overall distribution of
alleles on normal and disease chromosomes were tested
by Fisher’s exact test. Evidence for LD was established
using , where Fd is the frequency ofdp (F  F )/(1 F )d c c
carrier and Fc is the frequency of noncarrier chromo-
somes. A measure of allele-specific association, d is an
approximation of the population-attributable risk and
has desirable properties in a case/control study (Devlin
and Risch 1995). Nonsegregating alleles/haplotypes
were used for determination of allele/haplotype
frequency.
LD analysis in the overall MJD population revealed
significant results for at least one (and sometimes more
than one) allele for each marker (table 1). This result
could be indicative of haplotypes common to major clus-
ters of families that stand out in the overall group. At
the intragenic level, values of d were high for alleles
forming the A-C-A haplotype, suggesting that this hap-
lotype is common to most of the families under study.
The results presented in table 1 seem to indicate that the
A-C-A intragenic haplotype is conserved among most
families affected with MJD and is associated with several
different surrounding haplotypes. Detailed analysis of
the overall intragenic haplotype frequencies in families
affected by MJD and in control subjects (fig. 1 and table
2) revealed that all eight possible haplotypes defined by
the three intragenic polymorphisms occur in the control
population. In the families affected with MJD, only four
of these haplotypes were detected (A-C-A, G-G-C, A-G-
A, and G-C-C); however, in the majority (72%) of fam-
ilies, the disease allele was associated with the haplotype
formed by marker alleles A, C, and A. Interestingly, A-
C-A is the least common of the combinations found in
the control population, with a frequency of only 2%.
The G-G-C haplotype was significantly associated with
the disease allele in the families affected with MJD, even
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A-C-A 9 0 0 4
G-G-C 1 12 1a 3
NOTE.—“n” represents number of families for which full
phase-known haplotypes were determined at the three markers.
a Same extended haplotype seen in Sa˜o Miguel.
Table 4
Intragenic Haplotypes in the Non-Portuguese Families
COUNTRY OF ORIGIN
INTRAGENIC HAPLOTYPE
A-C-A G-G-C A-G-A G-G-A
Japan ( )np 16 15 1 … …
France ( )np 12 12 … … …
United States ( )anp 11 6 3 2 …
Germany ( )np 9 9 … … …
China/Taiwan ( )np 6 6 … … …
Brazil ( )np 5 4 1 … …
Spain ( )np 4 2 2 … …
Holland ( )np 1 1 … … …
Norway ( )np 1 1 … … …
Cambodia ( )np 1 1 … … …
Ivory Coast ( )np 1 1 … … …
British West Indies ( )np 1 1 … … …
Yemen ( )np 2 2 … … …
Morocco ( )np 1 … … 1 …
French Guyana ( )np 1 … … … 1
NOTE.—“n” represents number of families for which full phase-
known haplotypes were determined at the three markers.
a These families do not include the North American MJD families
that emigrated from the Azores.
though it is also the most common haplotype in the
control population.
To investigate the sources of specific haplotypes, we
proceeded to divide our collection of families affected
by MJD into groups with similar ethnic origins. We
started by constructing haplotypes for the Portuguese
and North American families originating from the
Azores (table 3). We analyzed a total of 23 families orig-
inating from the island of Flores, 15 families from the
island of Sa˜o Miguel, and 1 family from the island of
Graciosa (table 3 depicts only the full phase-known hap-
lotypes at the three markers; partial haplotypes are not
represented but are consistent with the full haplotypes).
The intragenic haplotype (A-C-A) associated with MJD
in families from Flores differed, at all three polymorphic
sites, from the haplotype observed in families from Sa˜o
Miguel (G-G-C). The D14S1015-D14S973-D14S1016-
D14S977-D14S995 haplotypes in the two islands were
also different, with 6-3-7-6-11 being the major haplo-
type in Flores, and 2-3-10-3/1-11 being the most com-
mon haplotype in Sa˜o Miguel; other variants of the prin-
cipal haplotype were found in families from both islands,
probably due to recombination events. Also, one family
from Flores presented with the G-G-C intragenic hap-
lotype and other alleles characteristic of the Sa˜o Miguel
families. The family from Graciosa had the full 2–G-G-
C–3–10–1–11 haplotype, the same as Sa˜o Miguel. For
Portuguese families originating from the mainland, both
intragenic haplotypes were detected.
Haplotype analysis in the families of non-Portuguese
origin was performed next (table 4). Kindreds from
countries with links to Portugal, such as Brazil and
Spain, were analyzed first: as was observed in mainland
Portugal, both A-C-A and G-G-C intragenic haplotypes
were detected. Inspection of the families with no obvious
links to Portugal revealed the presence of the A-C-A
intragenic haplotype in the vast majority of the families.
Exceptions included (1) the G-G-C haplotype in five kin-
dreds (Japan, British West Indies, and three families from
the United States), (2) an A-G-A haplotype in three fam-
ilies (Morocco and two families from the United States),
and (3) a G-G-A haplotype in one family from French
Guyana.
Interestingly, haplotypes for the surrounding markers
also provide some clues on the origin of the MJD mu-
tation. Even though families from most countries in the
world shared the same intragenic A-C-A haplotype, we
observed the presence of various flanking haplotypes as-
sociated with it. Furthermore, some of the extended
flanking haplotypes seemed to be specific to the country
of origin of the family, although there was variability
for these haplotypes, even between families from the
same country (there was not enough uniformity to per-
form a statistical analysis). Interestingly, some of the
French families share the extended haplotype seen for
the families from the island of Flores.
The finding that families originating from 16 different
countries from four continents share the same very rare
intragenic haplotype strongly suggests that this haplo-
type has a common ancestry. We propose that the mu-
tational event associated with the A-C-A haplotype ac-
counts for the presence of MJD in most countries in the
world. The fact that, in individual populations, this A-
C-A haplotype is associated with particular haplotypes
formed by some of the five markers surrounding the
MJD1 gene seems to indicate that (1) a single MJD mu-
tation was introduced in various populations, followed
by a local founder effect; and (2) this mutational event
is probably very old, since the extended haplotypes are
specific to the country of origin of the family. The G-G-
C haplotype found in Sa˜o Miguel and in a small number
of other families probably resulted from a different mu-
tational event. Other rare haplotypes found in countries
like Morocco, the United States, and French Guyana are
probably the result of independent mutations. Of these
rare haplotypes, A-G-A and G-G-A, we could speculate
that the latter resulted from the G-G-C haplotype by
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recombination and could well represent the same hap-
lotype; the A-G-A haplotype can hardly be explained by
the occurrence of recombination at the A-C-A haplo-
type, since the intragenic polymorphisms are so close
together, but this haplotype is rare enough that it could
have resulted from A-C-A by a single-nucleotide
substitution.
There now seems to be little doubt that two distinct
mutational events account for the presence of MJD in
the Azorean archipelago and in families of Azorean ex-
traction. The completely distinct haplotypes observed in
families from the two islands make it virtually impossible
that a single mutation was introduced into the Azores.
Genealogical studies performed by Lima et al. (1998)
strongly confirm, and complement, our findings.
It is tempting to speculate on how this mutation
spread, reaching the high prevalence it shows today. A
late-onset disease of dominant transmission, such as
MJD, could easily attain a relatively high frequency in
diverse populations. Sequeiros and Coutinho suggested
that the original mutational event occurred in mainland
Portugal, spreading to the Azores with its colonization
during the course of the 15th or 16th centuries and from
there to the United States and Canada, with the waves
of emigration from the archipelago at the end of last
century (Sequeiros and Coutinho 1993). Links with
other countries, more distant in time and space, could
be accounted for by the Portuguese sea explorations
starting in the mid-15th century. We cannot rule out,
however, the possibility that the mutational event as-
sociated with the A-C-A haplotype took place among
any of the other ethnic groups studied and was later
brought to the Azores and mainland Portugal. We could
speculate that the Flores mutation was introduced from
France, for instance, since some families originating from
both places share the same extended haplotype.
Another possibility is the existence of a haplotype that
predisposes for MJD. We addressed this issue elsewhere
(Maciel et al. 1999), using the same three intragenic
polymorphisms reported here, and showed a lack of as-
sociation between any of the intragenic haplotypes (in-
cluding A-C-A) and larger (CAG)n alleles in the normal
population, suggesting the absence of a predisposing
haplotype. It would be interesting to extend this study
to a larger and ethnically diverse control population.
In summary, our findings suggest the existence of two
introductions of the mutation into the Portuguese pop-
ulation. We show evidence worldwide for the existence
of a founder mutation accounting for the present dis-
tribution of Machado-Joseph disease.
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